Antidepressants, Antipsychotics, Anxiolytics, 2 Volume Set From Chemistry and Pharmacology to Clinical Application

by Buschmann, Helmut; Holenz, Jö rg; Pá rraga, Antonio; Torrens, Antoni; Vela, José Miguel; Díaz, José Luis

• ISBN13: 9783527310586
• ISBN10: 3527310584
• Edition: 1st
• Format: Hardcover
• Copyright: 2007-04-16
• Publisher: Wiley-VCH
• More Book Details

Summary

Antidepressants and related psychiatric drugs are the most important prescription drugs worldwide, accounting for a market volume of 20 billion US$ per year. This handbook provides a complete and detailed overview of all currently available psychiatric drugs, covering more than 250 different compounds.Particular features include: the most important information on the chemistry, pharmacology and therapeutic use of a given drug a special layout with margin notes and compound structures allowing for quick and easy access to the desired informationWritten by drug developers from the pharmaceutical industry, novel drugs currently under development and new methods of treatment are listed side by side with classical drugs, allowing a direct comparison of traditional and innovative therapeutic approaches.

Author Biography

The editors all work for the Spanish-based pharmaceutical company Esteve, a world leader in neuropharmaceuticals.
Helmut Buschmann is the research director of Esteve, in charge of the discovery and development of new active substances for a variety of neurological disorders. He was formerly the head of research at Gruenenthal, a Germany-based pharma company that also specialized in neuropharmaceuticals. During his time at Gruenenthal, he published a widely acclaimed book on analgesics that pioneered the integrated approach followed also in his most recent book.

Table of Contents

VOL. 1

ANTIDEPRESSANTS

Introduction to Depression and Bipolar Disorders

Trends in Treatment and Prevention

Marketed Drugs:

-tricyclic/tetracyclic antidepressants, adrenergic agents, serotonergic agents, dopaminergic agents, GABAergic agents, MAO inhibitors (partial list)

Drugs under Development:

-serotonin reuptake inhibitors, PDE inhibitors, CCH-releasing factors, melatonine products, AMPAkines, Substance-P antagonists (partial list)

ANXIOLYTICS

Introduction to Anxiety

Opportunities for Drug Intervention

Marketed Drugs:

- bezodiazepines, serotonergic drugs, GABAergic agents, dopaminergic agents, serotonin reuptake stimulants (partial list)

Drugs under Development:

- beta-carbolines, MAO inhibitors, 5-HT receptor antagonists, CCH-releasing factors, neurokinin ligands, melatonin agonists (partial list)

VOL. 2

ANTIPSYCHOTICS

Introduction to schizophrenia and other psychoses

Opportunities for Drug Intervention

Marketed Drugs:

- typical antipsychotics, atypical APs with dopaminergic and serotonergic activity (partial list)

Drugs under Development:

- AMPAkines, COMT inhibitors, tachykinin antagonists, anticholinergic agents, natural products and herbal remedies (partial list)

MEDICINES FOR ATTENTION DEFICIT /

HYPERACTIVITY DISORDER (ADHD)

Facts about ADHD

Marketed Drugs:

- psychostimulants, antidepressants

Drugs under Development:

- psychostimulants, antidepressants, AMPA receptor modulators, natural products and herbal remedies

Future of ADHD Therapy

9783527310586